Capricor Therapeutics, Inc. - Common Stock (CAPR) — AI analysis & news
Capricor Therapeutics, Inc. - Common Stock (CAPR) stock: 10 recent news items, neutral aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 10 indexed CAPR stories, aggregate finance-aware sentiment is neutral (+0.03 on a -1 to +1 scale).
Latest CAPR news
- CAPR Stock Rallies Into FDA Decision Month: Retail Spots Approval ‘Tea Leaves’ In Capricor’s Launch Team Hiring - Yahoo Finance · Yahoo Finance
- Caspian Therapeutics and Kura Oncology to host investor call By Investing.com - Investing.com UK · Investing.com UK
- Arecor Therapeutics raises £5 million through share placement By Investing.com - Investing.com Canada · Investing.com Canada
- Why Are Nasdaq Futures Rising Premarket? MU, TSLA, CAPR, VNDA, ASTS, HOOD, BA Stocks In Focus · Stocktwits
- Why Are Nasdaq Futures Rising Premarket? MU, TSLA, CAPR, VNDA, ASTS, HOOD, BA Stocks In Focus - Stocktwits · Stocktwits
- Arecor Therapeutics plans fundraising of up to £5.13 million By Investing.com - Investing.com Canada · Investing.com Canada
- Dow, S&P 500, Nasdaq Futures Mixed As 30-Year Yield Climbs Higher: CAPR, IOVA, DKNG, TTD In Focus - Yahoo Finance · Yahoo Finance
- CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens - Investing.com Canada · Investing.com Canada
- CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens - Investing.com India · Investing.com India
- CRISPR Therapeutics stock analysis: pipeline catalysts vs. financial reality - Investing.com · Investing.com
FAQ
What is the current sentiment for CAPR stock?
Aggregate finance-aware sentiment across the last 10 indexed CAPR news stories is neutral (+0.03 on a -1 to +1 scale).